Seeing Is Believing
KZR is currently covered by 2 analysts
Kezar Life Sciences's activity chart (see below) currently has 8 price targets and 13 ratings on display. The stock rating distribution of KZR is 50% HOLD and 50% BUY.
Analysts average stock forecasts to be materialized ratio is 62.5% with an average time for these price targets to be met of 299.25 days.
Highest price target for KZR is $6, Lowest price target is $6.
Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO on 17-Oct-2025. First documented stock forecast 05-May-2020.
Currently out of the existing stock ratings of KZR, 1 are a HOLD (50%), 1 are a BUY (50%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 14-Nov-2023
$5
$-2.29 (-31.41%)
$9
1 years 5 days ago
(17-Oct-2025)
0/6 (0%)
$-1.36 (-21.38%)
Buy Since 28-Jun-2022
$7
$-0.29 (-3.98%)
$20
1 years 5 days ago
(17-Oct-2025)
2/2 (100%)
$0.64 (10.06%)
273
Hold Since 02-Oct-2024
1 years 3 months 6 days ago
(16-Jul-2025)
2/4 (50%)
$64.1 (41.12%)
515
Hold Since 05-Oct-2023
$20
3 years 17 days ago
(05-Oct-2023)
1/1 (100%)
$-62.9 (-75.87%)
409
What is KZR (Kezar Life Sciences) average time for price targets to be met?
Which analyst most recently updated their price target on KZR (Kezar Life Sciences)?
Which analyst has the current lower performing score on KZR (Kezar Life Sciences) with a proven track record?
Which analyst has the most public recommendations on KZR (Kezar Life Sciences)?
Which analyst is the currently most bullish on KZR (Kezar Life Sciences)?
Which analyst is the currently most reserved on KZR (Kezar Life Sciences)?